Company Overview of Liquidia Technologies, Inc.
Liquidia Technologies, Inc., a nanotechnology company, designs, develops, and manufactures precisely engineered particles and films for applications in life and materials science sectors. It develops micro and nanoparticles for the delivery of biological and small molecule therapeutics, as well as for the development of vaccines and inhaled therapeutics in the life sciences sector. The company also develops nano-patterned optical films for displays, lighting, photovoltaics, and related applications in the material science sector. Liquidia Technologies, Inc. was founded in 2004 and is based in Research Triangle Park, North Carolina.
419 Davis Drive
Morrisville, NC 27560
Founded in 2004
Key Executives for Liquidia Technologies, Inc.
Chief Executive Officer and Director
Co-Founder and Senior Scientist
Compensation as of Fiscal Year 2015.
Liquidia Technologies, Inc. Key Developments
Liquidia Technologies Names Robert A. Lippe as Chief Operations Officer
Jul 14 15
Liquidia Technologies announced it has named Robert A. Lippe as the company’s chief operations officer, effective immediately. Mr. Lippe has responsibility for manufacturing research, process development, operations, quality control and compliance and will be a key member of the senior management team. Mr. Lippe has more than 25 years of experience in pharmaceutical operations, including bio-pharmaceutical manufacturing and compliance, supply chain, quality assurance and control, business process and operational excellence, facility engineering, and security program implementation. Prior to joining the company, Mr. Lippe served as an Executive Vice President, Operations & Chief Operations Officer at Alexza Pharmaceuticals where he had operational oversight, including the scale-up and optimization of supply that supported the launch of the company’s first commercial product, and advancement of a platform proof-of-concept that enabled acceleration of the company’s product pipeline.
Liquidia Technologies, Inc. Presents at CED Life Science Conference 2015, Mar-04-2015 11:15 AM
Feb 11 15
Liquidia Technologies, Inc. Presents at CED Life Science Conference 2015, Mar-04-2015 11:15 AM. Venue: Raleigh Convention Center, Raleigh, North Carolina, United States. Speakers: Neal F. Fowler, Chief Executive Officer and Director.
Liquidia Announces Formation of Lq3 Pharmaceuticals
Sep 10 14
Liquidia Technologies announced the formation of a new pharmaceutical company, Lq3 Pharmaceuticals, dedicated to advancing novel therapies for oral health conditions. Leveraging the PRINT(R) (Particle Replication In Non-Wetting Templates) technology, Lq3 will initially focus on research and preclinical development of a lead, but currently undisclosed oral health product candidate. Like Envisia Therapeutics, Lq3 will leverage the transformative PRINT technology, a micro- and nanoparticle development and manufacturing platform known for its unique ability to control particle size, shape and chemistry. The PRINT technology provides a basis for the creation of innovative products that have the potential to address significant unmet needs in a wide range of medical conditions.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|